Neuroscience
5-HTTLPR
14%
Acetate
14%
Agonist
15%
Amphetamine
72%
Antidepressant
34%
Atypical Antipsychotic
19%
Bipolar Disorder
35%
Blood Plasma
28%
Body Mass Index
14%
C-Reactive Protein
17%
Carfentanil
51%
Cell Excitability
24%
Depressive Disorder
41%
Dopamine Receptor D3
14%
Duloxetine
14%
Endorphin
79%
Functional Connectivity
17%
Functional Magnetic Resonance Imaging
24%
Gray Matter Volume
14%
Hostility
15%
Hypothalamic-Pituitary-Adrenal Axis
18%
Hypothalamus
16%
In Vivo
73%
Magnetic Resonance Imaging
14%
Magnetization Transfer
23%
Major Depressive Disorder
64%
Metabolic Pathway
29%
Methylene Blue
14%
Molecular Imaging
14%
Mood Disorder
14%
Multiple Sclerosis
64%
Myelin
14%
Negative Syndrome
28%
Neuroendocrinology
14%
Neurotrauma
14%
Panic Disorder
57%
Positive Syndrome
28%
positron emission tomographic scan
100%
Positron Emission Tomography
20%
Psilocybin
14%
Psychiatry
28%
Quetiapine
35%
Radioligand
23%
Randomized Controlled Trial
16%
Receptor
33%
Serotonin Release
14%
Synaptic Transmission
18%
Translocator Protein
66%
Treatment-Resistant Depression
28%
μ-Opioid Receptor
24%
Pharmacology, Toxicology and Pharmaceutical Science
Amisulpride
10%
Amphetamine
45%
Antidepressant
49%
Antipsychotic Drug
19%
Aripiprazole
15%
Atypical Antipsychotics
33%
Base
15%
Carbon 11
20%
Carbon Dioxide
28%
Carfentanil
24%
Cariprazine
9%
Clinical Pharmacokinetics
14%
Clinical Pharmacology
14%
Clinical Trial
21%
Clozapine
29%
Concomitant Drug
14%
Depressive Disorder
20%
Dexamphetamine
31%
Diseases
40%
Drug Induced Psychosis
14%
Duloxetine
14%
Endorphin
43%
Lurasidone
14%
Major Depression
33%
Naxagolide
14%
Negative Syndrome
27%
Normal Human
49%
Olanzapine
44%
Opiate Receptor
20%
Pharmacotherapy
14%
Positive Syndrome
17%
Psilocybin
14%
Psychotomimetic
14%
Psychotropic Agent
20%
Quetiapine
48%
Raclopride
14%
Randomized Controlled Trial
16%
Receptor
19%
Risperidone
23%
Self Poisoning
14%
Serotonin
15%
Side Effect
14%
Symptomatology
12%
Therapeutic Drug Monitoring
19%
Tolerability
32%
Toxic Injury
16%
Treatment Resistant Depression
28%
Tryptophan
14%
Ziprasidone
29%
μ-Opioid Receptor
23%
Medicine and Dentistry
Acidosis
7%
Antidepressant
33%
Arterial Spin Labeling
5%
Base
18%
Blood-Oxygen-Level Dependent
8%
Brain Blood Flow
5%
Carbon Dioxide
43%
Carbon Dioxide Breathing
14%
Clinical Study
9%
Cost-Effectiveness Analysis
28%
Depressive Disorder
11%
Diseases
28%
Drug Abuse
28%
DSM-IV
20%
Factor A
14%
Factor Analysis
9%
Functional Magnetic Resonance Imaging
14%
Health Care Cost
15%
Health Status
14%
Interleukin 6
5%
Involuntary Treatment
9%
Lipid Metabolism
9%
Magnetization Transfer
8%
Major Depressive Episode
5%
Medial Prefrontal Cortex
5%
Medicine
15%
Mitochondrial Membrane Transport Protein
7%
Multiple Sclerosis
14%
Negative Affectivity
14%
Panic Disorder
18%
Pathophysiology
9%
Patient with Depression
14%
Polyethylene Terephthalate
14%
Psilocybine
14%
Psychiatric Diagnosis
14%
Psychiatry
14%
Psychotomimetic
14%
Quetiapine
28%
Randomized Controlled Trial
16%
Recurrent Disease
9%
Short Form 36
9%
Somatics
14%
Subclinical Hypothyroidism
14%
Symptomatology
7%
Thyroid Disease
9%
Thyroxine
14%
Treatment Resistant Depression
28%
Treatment Response
7%
Visual Analog Scale
7%
Volunteer
18%
